RNF43 p.G659fs 通过 PI3K/AKT/mTOR 信号通路和 HLA-E 上调导致 MSI-high 结直肠癌中 NK 细胞功能障碍
RNF43 p.G659fs leads to natural killer cell dysfunction in MSI-high colorectal cancer through PI3K/AKT/mTOR signaling and HLA-E up-regulation.
CELL INTELLIGENCE · 肿瘤细胞治疗研究
肿瘤细胞治疗研究
英文原题:A novel natural killer cell-related signatures to predict prognosis and chemotherapy response of pancreatic cancer patients.
A novel natural killer cell-related signatures to predict prognosis and chemotherapy response of pancreatic cancer patients.
分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。
自然杀伤(NK)细胞参与癌症监视和清除。本研究旨在确定胰腺癌(PC)中NK细胞相关基因(NKG),并建立新的预后特征。
从TCGA、GEO和ICGC获取组学数据,利用NKG生成分子亚型并建立预后模型;NKG来自ImmPort数据库。比较亚型预后、免疫治疗应答和药物敏感性,并采用既往研究的12种程序性细胞死亡(PCD)模式。建立决策树和列线图预测预后。
识别出32个PC预后相关NKG,据此构建3个特征不同的分群;PCD模式更常见于C1或C3。分群间发现4个预后差异基因MET、EMP1、MYEOV和NGFR,据此在TCGA构建风险特征,并在PACA-CA及GSE57495队列验证。四基因表达与甲基化水平负相关。高低风险组预后、临床病理特征、免疫浸润、免疫治疗反应和药物敏感性显著不同。年龄、N分期和风险特征是PC预后独立因素;低风险组更易出现PCD。成功构建决策树及列线图,ROC和决策曲线分析显示预测能力稳健。
研究刻画了NKG来源的PC分子亚型并建立预后模型,可作为预测预后和制定个体化治疗的潜在工具。
Background: Natural killer (NK) cells are involved in monitoring and eliminating cancers. The purpose of this study was to develop a NK cell-related genes (NKGs) in pancreatic cancer (PC) and establish a novel prognostic signature for PC patients. Methods: Omic data were downloaded from The Cancer Genome Atlas Program (TCGA), Gene Expression Omnibus (GEO), International Cancer Genome Consortium (ICGC), and used to generate NKG-based molecular subtypes and construct a prognostic signature of PC. NKGs were downloaded from the ImmPort database. The differences in prognosis, immunotherapy response, and drug sensitivity among subtypes were compared. 12 programmed cell death (PCD) patterns were acquired from previous study. A decision tree and nomogram model were constructed for the prognostic prediction of PC. Results: Thirty-two prognostic NKGs were identified in PC patients, and were used to generate three clusters with distinct characteristics. PCD patterns were more likely to occur at C1 or C3.
Four prognostic DEGs, including MET, EMP1, MYEOV, and NGFR, were found among the clusters and applied to construct a risk signature in TCGA dataset, which was successfully validated in PACA-CA and GSE57495 cohorts. The four gene expressions were negatively correlated with methylation level. PC patients were divided into high and low risk groups, which exerts significantly different prognosis, clinicopathological features, immune infiltration, immunotherapy response and drug sensitivity. Age, N stage, and the risk signature were identified as independent factors of PC prognosis.
Low group was more easily to happened on PCD. A decision tree and nomogram model were successfully built for the prognosis prediction of PC patients. ROC curves and DCA curves demonstrated the favorable and robust predictive capability of the nomogram model. Conclusion: We characterized NKGs-derived molecular subtypes of PC patients, and established favorable prognostic models for the prediction of PC prognosis, which may serve as a potential tool for prognosis prediction and making personalized treatment in PC.
在 PubMed 查看 → 出版商原文(DOI) 全文 PDF(PMC)· 可下载 治疗专题与资料阅读指南 资料来源与翻译说明 报告译文或资料问题 →
MEMBER ACCOUNT
登录成功会直接打开下一页。